Sign inJoin waitlistJoin the waitlist

Jessie Alexander

Medical Director, Stanford Pediatric Stem Cell Transplantation · Stanford Health Care

Credentials: · · · · · ·

History

Stanford Pediatric Stem Cell Transplantation · Stanford Health Care
Present
Stanford Health Care
Present
Stanford Health Care
Present

St Jude Children's Research Hospital Bone Marrow Transplant and Cellular Therapy Fellowshop (2016) TN
2015–2016
Pediatric Hematology Oncology
University of Minnesota
2012–2015
Lucile Packard Children's Hospital (2012) CA
2009–2012
Creighton University School of Medicine
2005–2009

Research

Excellent outcomes following hematopoietic cell transplantation for Wiskott-Aldrich syndrome: a PIDTC report
Blood · 2020 · 110 citations
Infections in Infants with SCID: Isolation, Infection Screening, and Prophylaxis in PIDTC Centers
Journal of Clinical Immunology · 2021 · 51 citations
Human CD19-Targeted Mouse T Cells Induce B Cell Aplasia and Toxicity in Human CD19 Transgenic Mice
Molecular Therapy · 2018 · 48 citations

Michael Pulsipher
7 papers
Christopher Dvorak
6 papers
Donald Kohn
6 papers
Jennifer Puck
6 papers
LG
Linda Griffith
6 papers
Luigi Notarangelo
6 papers
Morton Cowan
6 papers
NK
Neena Kapoor
6 papers
Sung-Yun Pai
6 papers
TT
Troy Torgerson
6 papers
Ahmad Rayes
5 papers
Alfred Gillio
5 papers

Clinical trials

Phase 1b/2a Trial of Allogeneic HSCT From an HLA-partially Matched Related or Unrelated Donor After TCRab+ T-cell/CD19+ B-cell Depletion for Patients With Monogenic and/or Early-onset Medically Refractory Crohn Disease
Principal investigator · Not yet recruiting · Phase 1, Phase 2
Stanford University
2025–2040
Viral Specific T-Lymphocytes to Treat Infection With Adenovirus, Cytomegalovirus or Epstein-Barr Virus in Patients With Compromised Immunity
Principal investigator · Recruiting · Phase 1, Phase 2
Jessie L. Alexander
2025–2032
CD4^LVFOXP3 in Participants With IPEX
Principal investigator · Recruiting · Phase 1
Bacchetta, Rosa, MD
2022–2037
Viral Specific T-Lymphocytes to Treat Adenovirus, CMV and EBV
Principal investigator · Terminated · Phase 1, Phase 2
Jessie L. Alexander, MD
2020–2023